ADHD

A better understanding of this connection could yield preventative treatments.

Previous research have focused mostly on adults or patients with other comorbidities.

Participants with at least 3 psychiatric disorders more likely had a family history of psychiatric disorders.

Complex ADHD along with other comorbid psychiatric conditions increases the risk of mortality for patients.

Theresa R. Cerulli, MD, provides advice for clinicians on how to increase understanding of attention-deficit/hyperactivity disorders (ADHD) and encourage therapy adherence for both children and parents.

Dr. Theresa Cerulli reflects on exciting updates and unmet needs in the management and treatment of pediatric attention deficit hyperactivity disorders (ADHD).

Copy number variations were broadly associated with an increased risk of autism spectrum disorder and ADHD.

A key opinion leader considers the benefits of combining pharmacologic and nonpharmacologic treatments in the management of attention-deficit/hyperactivity disorder (ADHD) in children.

Theresa R. Cerulli, MD, reviews the use of viloxazine in managing pediatric attention-deficit/hyperactivity disorder (ADHD).

A neuropsychiatrist shares her thoughts on the relationship between substance abuse and attention-deficit/hyperactivity disorders (ADHD) in the pediatric population.

Theresa R. Cerulli, MD, describes the challenges comorbid psychiatric conditions pose in diagnosing attention deficit hyperactivity disorders (ADHD).

Dr Theresa Cerulli comments on whether neuropsychological testing in children for attention-deficit/hyperactivity disorder (ADHD) is needed.

An explanation of the typical predisposing factors in pediatric attention-deficit/hyperactivity disorder (ADHD).

An expert psychiatrist explains the neuroscience of attention-deficit/hyperactivity disorder (ADHD) in the pediatric population.

Theresa R. Cerulli, MD, provides an overview of the prevalence of attention-deficit/hyperactivity disorder (ADHD) in the pediatric population.

Few studies have focused on the psychosocial adjustments of siblings of children with ADHD.

In recent years there has been an expansion of trials in different methods of treatment settings, providers, countries, and delivery methods.

A combination of poor performance and methodological limitations were found for the machine learning models.

Dr. Glanzman presented during AAP 2021 about executive function impairments in patients with ADHD.

Students with ADHD have struggled with virtual schooling during the COVID-19 pandemic.

Executive function can include working memory, behavioral inhibition, and cognitive flexibility.

Dr. Chan said clinical practice guidelines ideally cover about 75% of patients with ADHD.

Children are now screened for autism at 18 and 24 months.

Immigrant children were less likely to be diagnosed with ADHD compared to children of US born parents.

The AAP guidelines for ADHD were first released in 2000 and last updated in 2019.